The advantages and disadvantages of adaptive designs for clinical trials
- 15 April 2004
- journal article
- review article
- Published by Elsevier BV in Drug Discovery Today
- Vol. 9 (8), 351-357
- https://doi.org/10.1016/s1359-6446(04)03023-5
Abstract
Flexible designs for clinical trials permit mid-trial design modifications, which are based on interim information from inside or outside the trial while meeting (regulatory) requirements for the control of the type I error rate. The basic principle is to combine stage standardized test statistics such as p-values or z-scores in a pre-specified way. The flexibility covers changes of sample sizes, treatment allocation ratios and the number of interim analyses, as well as the selection of treatments, doses and end points. The price to be paid is that non-standard test statistics must be used after an adaptation.Keywords
This publication has 48 references indexed in Scilit:
- Recursive Combination TestsJournal of the American Statistical Association, 2002
- The Na+/H+exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction11This manuscript is dedicated to the memory of Karl-Ludwig Neuhaus (1944–2000).Journal of the American College of Cardiology, 2001
- Adaptive Sample Size Calculations in Group Sequential TrialsBiometrics, 1999
- Modification of Sample Size in Group Sequential Clinical TrialsBiometrics, 1999
- Randomized Play-the-Winner Clinical TrialsControlled Clinical Trials, 1999
- Combining different phases in the development of medical treatments within a single trialStatistics in Medicine, 1999
- Evaluation of Experiments with Adaptive Interim AnalysesPublished by JSTOR ,1994
- Sequential Tests of Hypotheses in Consecutive TrialsBiometrical Journal, 1989
- Play the Winner Rule and the Controlled Clinical TrialJournal of the American Statistical Association, 1969
- Some aspects of the sequential design of experimentsBulletin of the American Mathematical Society, 1952